DEF: Jaguar Health Seeks Stockholder Approval for Reverse Stock Split to Regain Nasdaq Compliance

Jaguar Health is asking stockholders to approve a reverse stock split at a ratio between 1-for-15 and 1-for-40 to meet Nasdaq's minimum bid price requirement and potentially attract a broader range of investors.

Summary

• Jaguar Health is holding a Special Meeting of Stockholders on March 13, 2025, to vote on two proposals.
• The first proposal is to approve an amendment to the company's Third Amended and Restated Certificate of Incorporation to effect a reverse stock split of its common stock at a ratio between 1-for-15 and 1-for-40.
• The exact ratio will be determined by the Board of Directors within one year of approval and publicly announced.
• The primary reason for the reverse stock split is to increase the stock price to meet Nasdaq's minimum bid price requirement of $1.00 per share.
• The company believes this may also make the stock more attractive to institutional investors and improve trading liquidity.
• The second proposal is to approve one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if there are not enough votes to approve the first proposal.
• Stockholders of record as of February 18, 2025, are entitled to vote.
• The Board of Directors recommends voting FOR both proposals.

Sentiment

Score: 6

Explanation: The document is primarily procedural, outlining the details of a reverse stock split. While the company expresses optimism about the potential benefits, the inherent risks and uncertainties associated with reverse stock splits temper the overall sentiment.

Positives

• The reverse stock split aims to increase the stock price to meet Nasdaq's minimum bid price requirement, which is crucial for continued listing.
• A higher stock price may attract a broader range of institutional investors and improve trading liquidity.
• The Board of Directors has the flexibility to determine the appropriate reverse stock split ratio within the approved range.
• The company believes the reverse stock split is in the best interests of the company and its stockholders.

Negatives

• Reverse stock splits can have a negative perception among some investors.
• There is no guarantee that the reverse stock split will increase the stock price or prevent future declines.
• The total market capitalization of the company may decrease after the reverse stock split.
• The increased number of authorized but unissued shares could lead to dilution and potential misuse for anti-takeover measures.

Risks

• The stock price may not increase sufficiently to maintain Nasdaq compliance after the reverse stock split.
• Failure to comply with Nasdaq listing standards could lead to delisting, which would negatively affect the company's ability to raise capital.
• The market price of the common stock may fluctuate and potentially decline after the Reverse Stock Split, such as the decline in the market price of our Common Stock that we experienced after our previous reverse stock splits effectuated on June 1, 2018, June 7, 2019, September 8, 2021, January 23, 2023 and May 23, 2024.
• The resulting per-share market price may not attract institutional investors or investment funds and may not satisfy the investing guidelines of such investors and, consequently, the trading liquidity of our Common Stock may not improve.
• A decline in the market price of our Common Stock after the Reverse Stock Split is approved and effected may result in a greater percentage decline than would occur in the absence of the Reverse Stock Split.

Future Outlook

The company intends to actively monitor the trading price of its Common Stock and consider available options to resolve non-compliance with Nasdaq listing rules if the reverse stock split is not approved.

Management Comments

• Lisa A. Conte, Chief Executive Officer & President: 'It is important that your shares be represented and voted whether or not you plan to attend the Special Meeting in person.'
• The Board of Directors believes that authority granted to the Board of Directors to effect the Reverse Stock Split is in the Company's and the stockholders best interests.

Industry Context

Reverse stock splits are a common strategy for companies facing delisting from exchanges due to low stock prices. Other companies in similar situations may consider this approach to regain compliance and attract investors.

Comparison to Industry Standards

• Many small-cap and micro-cap companies facing Nasdaq compliance issues have implemented reverse stock splits.
• Comparable companies that have recently undergone reverse stock splits include those in the biotechnology and pharmaceutical sectors, which often experience stock price volatility.
• The success of a reverse stock split in maintaining compliance and improving stock price varies depending on the company's underlying financial performance and market conditions.

Stakeholder Impact

• Shareholders will be impacted by the reverse stock split, potentially seeing a change in the number of shares they own and the per-share price.
• Employees may be affected by the company's ability to remain listed on Nasdaq, which could impact morale and job security.
• The company's ability to raise capital and fund operations could be affected by the outcome of the vote and its Nasdaq listing status.
• Customers and suppliers may be indirectly affected by the company's financial stability and access to capital.

Next Steps

• Stockholders to vote on the proposed reverse stock split and adjournment proposal at the Special Meeting on March 13, 2025.
• Board of Directors to determine the exact reverse stock split ratio within the approved range if the proposal is approved.
• Company to publicly announce the selected ratio and file an amendment to the Certificate of Incorporation.
• If the reverse stock split is not approved, the company will monitor the stock price and consider other options to regain Nasdaq compliance.

Key Dates

Keywords

reverse stock split, Nasdaq, minimum bid price, stockholders, proxy statement, common stock, Jaguar Health, listing, compliance, investors